L4C-15507-02872
2 vaccinations
1 coded response
15 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 347 / FL
- Registered
- 2021-10-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-18
Dose 1 — Pfizer-BioNTech
-
2021-10-05
Registered in v-safe
- 2021-10-05
-
2021-10-09
Dose 2 — Pfizer-BioNTech
- 2021-10-09
- 2021-10-10
- 2021-10-11
- 2021-10-12
- 2021-10-13
- 2021-10-15
- 2021-10-17
- 2021-10-23
- 2021-10-31
- 2021-11-07
- 2021-11-13
- 2021-11-22
- 2022-01-08
-
2022-04-14
Survey response — 6 months, dose 2MedDRA: Cough, Headache, Oropharyngeal pain, Unevaluable event — Feeling: FairFree text: Sore throat, cough, temperature, headache.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-18 | Pfizer-BioNTech | No |
| 2 | 2021-10-09 | Pfizer-BioNTech | No |
Free text
Release 11 — 6 months, dose 2
Symptoms: Sore throat, cough, temperature, headache.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release